Quantcast

Ophthotech (OPHT) Jumps: Stock Rises 11.9%


Shutterstock photo

Ophthotech Corporation OPHT was a big mover last session, as the company saw its shares rise nearly 12% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $69.68-$76.25 in the past one-month time frame, witnessed a sharp increase yesterday.

The Zacks Consensus Estimate for the current quarter has moved lower in the past 60 days, suggesting that there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.   

Ophthotech currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Ophthotech Corporation Price and Consensus

Ophthotech Corporation Price and Consensus | Ophthotech Corporation Quote

A better ranked stock in the  Medical - Biomedical and Genetics industry is Myriad Genetics, Inc. MYGN which carries a Zacks Rank #1 (Strong Buy). You can see  the complete list of today's Zacks #1 Rank (Strong Buy) stocks here .

Is OPHT going up? Or down? Predict to see what others think: Up or Down

Today's Stocks from Zacks' Hottest Strategies

It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively.

And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.

See Them Free>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Myriad Genetics, Inc. (MYGN): Free Stock Analysis Report

Ophthotech Corporation (OPHT): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



This article appears in: Investing , Investing Ideas , Stocks
Referenced Symbols: MYGN , OPHT


More from Zacks.com

Subscribe






Zacks.com
Contributor:

Zacks.com

Equity Research








Research Brokers before you trade

Want to trade FX?





Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com